These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 16706824

  • 1. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
    Kojiro S, Yano H, Ogasawara S, Momosaki S, Takemoto Y, Nishida N, Kojiro M.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
    [Abstract] [Full Text] [Related]

  • 2. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M.
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [Abstract] [Full Text] [Related]

  • 3. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
    Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1277-86. PubMed ID: 15709199
    [Abstract] [Full Text] [Related]

  • 4. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
    Xiao YS, Zhou J, Tang ZY, Fan J, Wu ZQ, Liu YK, Ye SL, Shen ZZ, Xue Q, Zhao Y.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3205-9. PubMed ID: 16405841
    [Abstract] [Full Text] [Related]

  • 5. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
    Oie S, Ono M, Yano H, Maruyama Y, Terada T, Yamada Y, Ueno T, Kojiro M, Hirano K, Kuwano M.
    Int J Oncol; 2006 Dec 30; 29(6):1469-78. PubMed ID: 17088986
    [Abstract] [Full Text] [Related]

  • 6. Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization.
    Noguchi R, Yoshiji H, Ikenaka Y, Kitade M, Kaji K, Yoshi J, Yanase K, Namisaki T, Yamazaki M, Tsujimoto T, Akahane T, Uemura M, Fukui H.
    Int J Oncol; 2008 Jan 30; 32(1):193-9. PubMed ID: 18097559
    [Abstract] [Full Text] [Related]

  • 7. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.
    Zhao J, Zhang X, Shi M, Xu H, Jin J, Ni H, Yang S, Dai J, Wu M, Guo Y.
    Hepatology; 2006 Jul 30; 44(1):205-15. PubMed ID: 16799960
    [Abstract] [Full Text] [Related]

  • 8. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M.
    J Hepatol; 2007 Jan 30; 46(1):77-88. PubMed ID: 17045692
    [Abstract] [Full Text] [Related]

  • 9. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
    Yanase K, Yoshiji H, Ikenaka Y, Noguchi R, Kitade M, Kaji K, Yoshii J, Namisaki T, Yamazaki M, Asada K, Tsujimoto T, Akahane T, Uemura M, Fukui H.
    Oncol Rep; 2007 Feb 30; 17(2):441-6. PubMed ID: 17203185
    [Abstract] [Full Text] [Related]

  • 10. [Anti-tumor effects of various interferons-alpha +5-fluorouracil via downregulation of dihydropyrimidine dehydrogenase in hepatoma cells].
    Fan XY, Uchida H, Iwaki K, Kai S, Shibata K, Ohta M, Kitano S.
    Gan To Kagaku Ryoho; 2007 Jun 30; 34(6):957-9. PubMed ID: 17565266
    [Abstract] [Full Text] [Related]

  • 11. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
    Liu J, Qi S, Zhu H, Zhang J, Li Z, Wang T.
    Chin Med J (Engl); 2002 May 30; 115(5):759-62. PubMed ID: 12133551
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells.
    Murakami M, Kobayashi S, Marubashi S, Tomimaru Y, Noda T, Wada H, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H.
    Ann Surg Oncol; 2011 Feb 30; 18(2):589-96. PubMed ID: 20811948
    [Abstract] [Full Text] [Related]

  • 13. Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.
    Zhang T, Sun HC, Zhou HY, Luo JT, Zhang BL, Wang P, Wang L, Qin LX, Ren N, Ye SL, Li Q, Tang ZY.
    Cancer Lett; 2010 Apr 28; 290(2):204-10. PubMed ID: 19822391
    [Abstract] [Full Text] [Related]

  • 14. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S, Kubota T, Watanabe M, Furukawa T, Tanino H, Ishibiki K, Teramoto T, Kitajima M.
    Anticancer Res; 1993 Apr 28; 13(2):369-73. PubMed ID: 8517649
    [Abstract] [Full Text] [Related]

  • 15. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
    Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST.
    Clin Cancer Res; 2010 Feb 01; 16(3):967-77. PubMed ID: 20103676
    [Abstract] [Full Text] [Related]

  • 16. High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.
    Wang L, Tang ZY, Qin LX, Wu XF, Sun HC, Xue Q, Ye SL.
    Hepatology; 2000 Jul 01; 32(1):43-8. PubMed ID: 10869287
    [Abstract] [Full Text] [Related]

  • 17. Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.
    Noguchi R, Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Mitoro A, Tsujinoue H, Imazu H, Masaki T, Fukui H.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):6038-45. PubMed ID: 14676130
    [Abstract] [Full Text] [Related]

  • 18. Effects of interferon-alpha on recurrence and metastasis of hepatocellular carcinoma after curative resection in nude mice.
    Wang L, Tang Z, Xue Q, Sun H, Chen J, Gao D, Zhao Y, Chen J, Sun R, Liu Y, Ye S.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun 01; 9(3):154-6. PubMed ID: 11412390
    [Abstract] [Full Text] [Related]

  • 19. Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells.
    Gao FJ, Cui SX, Chen MH, Cheng YN, Sun LR, Ward SG, Kokudo N, Tang W, Qu XJ.
    Life Sci; 2008 Dec 05; 83(23-24):815-20. PubMed ID: 18976674
    [Abstract] [Full Text] [Related]

  • 20. Growth inhibitory effects of IFN-beta on human liver cancer cells in vitro and in vivo.
    Ogasawara S, Yano H, Momosaki S, Akiba J, Nishida N, Kojiro S, Moriya F, Ishizaki H, Kuratomi K, Kojiro M.
    J Interferon Cytokine Res; 2007 Jun 05; 27(6):507-16. PubMed ID: 17572015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.